Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (828)	9/18/2001 2:04:14 PM
From: tuck	Read Replies (1) \| Respond to of 1784

Trickle does not understand BCOR's spanking today, this is the only news I can find and it's not bad: >>UPPSALA, Sweden, Sep 18, 2001 /PRNewswire via COMTEX/ -- Biacore International AB (Biacore) (Nasdaq: BCOR chart, msgs; SSE: chart, msgs) today announced the launch of its Biacore(R) C system for rapid concentration analysis in drug development, manufacturing quality control (QC) and in-process control applications. Biacore C is the first SPR-based system for QC applications designed specifically for compliance with regulatory requirements. As drug companies are increasingly faced with the pressure of bringing new products to market faster while still maintaining strict compliance with Good Laboratory (GLP)/Good Manufacturing Practice (GMP), the validation of analytical systems and procedures becomes a major rate-limiting step. Biacore C was specifically developed with regulatory requirements in mind, and is expected to reduce time for biomolecular analysis while meeting the highest demands for accuracy, sensitivity and reproducibility. Biacore C combines the advantages of the Company's non-label Surface Plasmon Resonance (SPR) technology with advanced instrumentation and software to offer an unparalleled level of performance and reliability. The new system is optimized for fully automated concentration analysis with advanced data evaluation and automatic report capabilities. Biacore C Control Software is designed to support the GLP/GMP regulated working processes with built-in validation features for observance of worldwide regulations. Biacore C provides improved quantitative and qualitative concentration determinations that offer: * Real-time data analysis * Wizard based software for assay development and concentration analysis * State-of-the-art validation features * Low sample usage/ low reagent usage Launched in conjunction with Biacore C is a new customer validation service, which further supports the customer's efforts to conform to generally accepted GLP/GMP standards. This unique package provides for installation and operational qualification (IQ/OQ) documentation upon system delivery and on- site IQ/OQ performance. A maintenance requalification service is also included to ensure the system is maintained in a validated state. "Biacore C incorporates the knowledge, experience, engineering and validation skills of Biacore International in expanding and improving QC applications with the highest performance systems available", commented Fredrik Sundberg, Marketing Manager for Drug Development, QC & Validation, Pharmaceutical and Biotech Business Unit at Biacore. "We are fully committed to bringing new technologies to market that offer drug discovery and drug development companies advantages in quality, reliability and throughput of data from the early stages of research to the strict regulatory environment of drug manufacturing."<< This is a firesale candidate right now. Sheeesh. Edit: OTOH, ABI got an upgrade from CSFB, probably deserved. Cheers, Tuck